Compare Live Nation Entertainment, Inc. (LYV) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs Smith & Nephew plc — how do they compare? Live Nation Entertainment, Inc. trades at $180.98 (market cap $42.09B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Live Nation Entertainment, Inc. is far larger — about 3.3× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.57% dividend while Live Nation Entertainment, Inc. pays none. Which is the better fit depends on your goals.
| LYV | SNN | |
|---|---|---|
Market Cap | $42.09B | $12.64B |
Sector | Industrials | Health |
52-Week High | $186.59 | $38.70 |
52-Week Low | $125.61 | $28.73 |
Enterprise Value | $43.59B | $15.41B |
Dividend Yield | — | 2.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
